Antimalarial drug touted by Trump linked to increased risk of death in coronavirus patients, study says - The Boston Globe

Antimalarial drug touted by Trump linked to increased risk of death in coronavirus patients, study says - The Boston Globe: The study, obtained early by The Washington Post and published Friday in the medical journal the Lancet, is the largest analysis to date of the risks and benefits of treating COVID-19 patients with antimalarial drugs.